Glycemic Control – Medxy AI

Mobile Text Messaging Enhances Glycemic and Blood Pressure Control in Adults with Uncontrolled Type 2 Diabetes

By MedXY 09/10/2025

A randomized trial in China shows that a 12-month mobile message-based intervention modestly improves HbA1c and systolic blood pressure in patients with uncontrolled type 2 diabetes, supporting mHealth strategies to manage cardiovascular risks.

Clinical Updates Wellness & Lifestyle

Fruit Juice or Whole Fruit for Breakfast in Type 2 Diabetes? Understanding Blood Sugar Control Challenges

By MedXY 08/25/2025

A recent randomized trial shows that consuming 100% orange juice, whole orange pieces, or a sugar-sweetened beverage with breakfast results in similar acute postprandial glycemic responses in well-controlled type 2 diabetes patients.

Clinical Updates Wellness & Lifestyle

Berberine Ursodeoxycholate (HTD1801): A Promising Oral Therapy for Type 2 Diabetes with Multifaceted Metabolic Benefits

By MedXY 08/24/2025

A phase 2 randomized trial shows berberine ursodeoxycholate (HTD1801) significantly reduces HbA1c and improves liver and cardiometabolic parameters in type 2 diabetes patients inadequately controlled with diet and exercise, with a favorable safety profile.

Clinical Updates Wellness & Lifestyle

Berberine and Cinnamon Synergy: A Promising Adjunct Therapy for Improving Glycemic Control and LDL Cholesterol in Type 2 Diabetes

By MedXY 08/24/2025

A 12-week randomized controlled trial demonstrated that supplementation with berberine plus cinnamon significantly lowers fasting blood sugar, HbA1c, and LDL cholesterol in patients with type 2 diabetes, offering potential for improved cardiometabolic risk management.

Clinical Updates Wellness & Lifestyle

Adjunct-to-Insulin Therapy Using SGLT2 Inhibitors in Youth with Type 1 Diabetes: Clinical Impact and Renal Outcomes

By MedXY 08/21/2025

SGLT2 inhibitors adjunct to insulin improve glycemic control, reduce hyperfiltration, and are generally safe in youth with type 1 diabetes under careful ketone monitoring and DKA risk mitigation.

Clinical Updates Wellness & Lifestyle

Harnessing Digital Therapeutics to Improve Glycemic Control in Type 2 Diabetes: Insights from the BRIGHT Trial

By MedXY 08/20/2025

The BRIGHT trial evaluates AspyreRx, a digital cognitive behavioral therapy, for enhancing glycemic control in type 2 diabetes patients with residual hyperglycemia on stable medical therapy, focusing on efficacy, safety, and real-world applicability.

Clinical Updates Wellness & Lifestyle

Sustained Metabolic Benefits of a Remote Ketogenic Nutrition Program in Veterans with Type 2 Diabetes: A 3-Year Observational Study

By MedXY 08/11/2025

A 3-year observational study demonstrates that a remotely delivered ketogenic nutrition program leads to sustained improvements in glycemic control, weight, medication use, and metabolic markers among US veterans with type 2 diabetes.

Medical News Wellness & Lifestyle

Anaerobutyricum soehngenii: A New Hope for Glycemic Control

By MedXY 08/11/2025

Anaerobutyricum soehngenii supplementation shows promise in improving glycemic control and cardiovascular health in at-risk adults.

Clinical Updates Wellness & Lifestyle

Once-Weekly Insulin Regimens in Type 2 Diabetes: Comparative Efficacy, Safety, and Clinical Implications from COMBINE 3 and QWINT Trials

By MedXY 08/02/2025

Once-weekly insulin regimens (IcoSema, efsitora alfa) demonstrate non-inferior glycemic control compared to daily injections in type 2 diabetes, with advantages in hypoglycemia risk, weight, and injection burden.

Wellness & Lifestyle

Revolutionizing Diabetes Management in Pregnancy with Hybrid Closed-Loop Technology

By MedXY 07/29/2025

A groundbreaking trial highlights how hybrid closed-loop systems improve glycemic control for pregnant women with type 1 diabetes, offering enhanced maternal and fetal health outcomes.